loader
Please Wait
Applying Filters...

Quotient Sciences Quotient Sciences

X

Approved Drug Products containing 204629 listed in the FDA Orange Book. Original Data : FDA Website

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 BOEHRINGER INGELHEIM (2)

filter

01 TABLET;ORAL (2)

filter

01 RX (2)

filter

01 JARDIANCE (2)

filter

01 Yes (2)

URL Supplier Web Content
TABLET; ORAL
10MG
2014-08-01
204629
JARDIANCE
RX
Yes
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET; ORAL
25MG
2014-08-01
204629
JARDIANCE
RX
Yes
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for FDA Orange Book APPLICATION 204629

Looking for FDA Orange Book APPLICATION 204629 2

19

Boehringer Ingelheim GmbH, based in Germany, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is EMPAGLIFLOZIN, with a corresponding application number 204629.

Regulatory Information RX

With a dosage strength 10MG

Dosage Form Route TABLET; ORAL

Reference Listed Drug Yes

Approved since 2014-08-01

18

Boehringer Ingelheim GmbH, based in Germany, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is EMPAGLIFLOZIN, with a corresponding application number 204629.

Regulatory Information RX

With a dosage strength 25MG

Dosage Form Route TABLET; ORAL

Reference Listed Drug Yes

Approved since 2014-08-01

Post Enquiry
POST ENQUIRY